Ajinomoto, a serious meals producer, is getting into the sphere of medication to deal with genetic illnesses. We will purchase an American enterprise firm for about 80 billion yen to strengthen the healthcare area, which is anticipated to develop.
Ajinomoto, a serious meals producer, is getting into the sphere of medication to deal with genetic illnesses. We will purchase an American enterprise firm for about 80 billion yen to strengthen the healthcare area, which is anticipated to develop.